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Stenting Trial (CREST): Flaws in CREST and its Interpretation
Paraskevas K.I., Mikhailidis D.P., Liapis C.D., Veith F.J. Eur J Vasc
Endovasc Surg 2013;45:539-45.
The Carotid Revascularization Endarterectomy versus Stenting Trial
(CREST) has been used to support the equivalence of carotid artery stent-
ing (CAS) and carotid endarterectomy (CEA) in the treatment of carotid
stenosis in both symptomatic and asymptomatic patients. This inclusion
of two different forms of the disease decreased the power and signiﬁcance
of the CREST results and weakened the trial. Other ﬂaws in CREST
were the equal weighting of mostly minor myocardial infarctions (MIs)
with strokes and death in the peri-procedural, composite ‘end’ point, but
not in the 4-year, long-term ‘end’ point. Although CAS was associated
with 50% fewer peri-procedural MIs compared with CEA, there were
>2.5-fold more MIs after CAS than CEA at 4 years. The 4-year MI rate,
however, was not a component of the primary ‘end’ point. Additionally,
although the initial CREST report indicated that there was no difference
in the outcomes of CAS and CEA according to symptomatic status or
sex, subsequent subgroup analyses showed that CAS was associated with
signiﬁcantly higher stroke and death rates than CEA in symptomatic
patients, in females and in individuals $65 years of age. The present article
will examine these and other ﬂaws and the details of CREST's results
derived from the trial's preplanned subanalyses to show why the claims
that CREST demonstrates equivalence of the two therapeutic procedures
are unjustiﬁed.
Interprocedural Comparison of Changes in Natural Flow Velocity
Patterns in the Internal Carotid Artery Following CAS or CEA
Reichmann B.L., Hellings W.E., van der Worp H.B., Nederkoorn P.J.,
Algra A., Brown M.M., Moll F.L., Mali W.P.Th.M., de Borst G.J. Eur J
Vasc Endovasc Surg 2013;45:552-9.
Background and purpose: Different ﬂow velocities have been re-
ported after carotid angioplasty with stenting (CAS) than after carotid
endarterectomy (CEA). We compared blood ﬂow velocities following
CAS and CEA in the International Carotid Stenting Study (ICSS;
ISRCTN25337470).
Materials and methods: In total, 254 patients (70% male; 129 CAS
and 125 CEA) were included. Mean peak systolic velocities (PSVICA) were
assessed at baseline, 30 days, 1 and 2 years. Following both treatments,
restenosis $50% was deﬁned as PSVmean >125 cm s
1.
Results: CAS and CEA resulted in a similar reduction in PSVICA
1 month after treatment. Post-intervention analysis for each treatment sepa-
rately revealed that PSVICA following CAS increased signiﬁcantly during
follow-up (30 days to 2 years; 22.4 cm s1; 95% conﬁdence interval (CI),
14.3 to 30.5). On the contrary, PSVICA following CEA remained relatively
stable during follow-up (4.7 cm s1; 95% CI, 6.5 to 15.9). When we ana-
lysed the increase in PSVICA between both treatments after 2 years of
follow-up, no signiﬁcant interprocedural difference was observed. The
internal carotid artery/common carotid artery (ICA/CCA) PSV ratio
increased after CAS but not after CEA: 1.2 vs 1.1 (0.04, 95% CI; 0.16
to 0.25) at 30 days; 1.5 vs 1.1 (0.39, 95% CI; 0.13 to 0.65) at 1 year;
and 1.5 vs 1.1 (0.36; 95% CI, 0.08 to 0.63) at 2 years. The rate of apparent
ipsilateral ICA restenosis >50% was higher following CAS (hazard ratio
2.35; 95% CI, 1.35 to 4.09).
Conclusion: Two years after carotid revascularisation, no signiﬁcant
interprocedural difference was observed in the increase of PSVICA between
CAS and CEA. However, the ICA/CCA ratio increased more following
CAS resulting in an apparent higher rate of restenosis following CAS.
Carotid Endarterectomy after Intravenous Thrombolysis for Acute
Cerebral Ischaemic Attack: Is It Safe?
Rathenborg L.K., Jensen L.P., Baekgaard N., Schroeder T.V. Eur J Vasc
Endovasc Surg 2013;45:571-5.
Objectives: Intravenous thrombolysis (IVT) has proven effective in
the treatment of acute cerebral ischaemic attack in selected cases. In the
presence of a carotid artery stenosis, such patients may be candidates for
carotid endarterectomy (CEA). Few studies have been made on the safety
of CEA performed after IVT.1722Design: This was a retrospective study. Data including 30 days'
follow-up were obtained from medical records and from a vascular registry.
Materials: A consecutive series of 306 patients were operated on for
symptomatic carotid artery stenosis during a 5-year period. Among these,
22 (7%) patients had been treated with IVT for an acute cerebral ischaemic
attack prior to CEA and 284 (93%) patients had CEA only.
Methods: IVT as well as CEA was performed following established
guidelines. CEA was performed in median 11 days (25 and 75% percentiles:
7-13 days) after the neurological index event in patients having undergone
IVT and 12 days (25 and 75% percentiles: 8-21 days) in patients undergoing
CEA only.
Results: The 30 days' stroke and death rate was 0% (95% conﬁdence
interval (CI): 0-15%) in patients who had IVT before CEA and 2.4% (95%
CI: 0.9-4.7%) in patients who underwent CEA only.
Conclusion: Our experience indicates that CEA performed after IVT
for acute cerebral ischaemic attack is safe, conﬁrming existing but sparse
publications. However, our series is small and our study possesses a number
of limitations. Thus, our results cannot necessarily be transferred to other
units, who instead should perform similar studies, preferably together.
Open Abdomen Treatment after Aortic Aneurysm Repair with
Vacuum-assisted Wound Closure and Mesh-mediated Fascial Traction
Sörelius K., Wanhainen A., Acosta S., Svensson M., Djavani-Gidlund K.,
Björck M. Eur J Vasc Endovasc Surg 2013;45:586-92.
Objectives: Open abdomen (OA) treatment is sometimes necessary
after surgery for aortic aneurysm (AA), to prevent or treat abdominal
compartment syndrome (ACS). A multicentre study evaluating vacuum-
assisted wound closure (100-150 mmHg) and mesh-mediated fascial trac-
tion (VAWCM) was performed.
Methods: All patients treated with OA after AA repair (2006-2009)
were prospectively registered at four centres; those treated <5 days were
excluded. All surviving patients underwent a 1-year follow-up, including
computed tomography (CT) examination.
Results: Among 1041 patients treated with open or endovascular
repair of AA, 28 (2.9%) had OA treatment with VAWCM; another two
had VAWCM after hybrid operations for thoraco-abdominal AA. Eighteen
(60%) were operated on for rupture and 12 (40%) electively. Eight had
suprarenal or thoraco-abdominal aneurysms. Eight (27%) died within 30
days, none due to OA-related complications. Four died before abdominal
closure; primary delayed fascial closure was achieved in all survivors. One-
year mortality was 50%. Ten (33%) had bowel ischaemia requiring bowel
resection.
Late potential OA-related infectious complications occurred in ﬁve
(17%), all of whom ﬁrst developed intestinal ischaemia: entero-atmospheric
ﬁstulae (two), graft infections (two), aorto-enteric ﬁstula (one). One year
follow-up with clinical evaluation and CT showed no signs of graft infection.
Incisional hernias occurred in 9 of 15 patients (60%); only three were
symptomatic.
Conclusion: VAWCM provided high fascial closure rate after AA
repair and long-term OA treatment. Infectious complications occur after
intestinal ischaemia and prolonged OA treatment, and are often fatal. The
poor prognosis among patients needing OA after AA surgery may be
improved by using VAWCM, permitting earlier closure.
Uptake of Abdominal Aortic Aneurysm Screening. A Cohort Study
Ross N.P., Scott N.W., Duncan J.L. Eur J Vasc Endovasc Surg
2013;45:608-13.
Background: Abdominal aortic aneurysms (AAA) are responsible for
1.4% of UK deaths. Deprivation is a risk factor for AAA. Screening reduces
AAA related mortality and is cost effective if uptake remains high. The
Highland aneurysm screening programme (HASP) began in 2001 offering
screening to men in a sparsely populated area. The aim was to identify
whether uptake varies with deprivation or rurality, in the context of an
established programme.
Methods: Retrospective interrogation of HASP records was per-
formed on all men offered screening from 2001 until 2010. Deprivation
and rurality status were derived from postcode of residence (SIMD’09 and
URC’08) and the relationships with screening uptake were examined.
